TLSA
TLSA
NASDAQ · Biotechnology

Tiziana Life Sciences Ltd

$1.36
+0.09 (+7.09%)
As of Feb 8, 2:07 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,689.7% upside
Low Target $25.58
Average Target $37.94
High Target $45.71
Current Price $1.36
Current
$1.36
Target
$37.94
$25.58 $37.94 avg $45.71
Scenario Analysis
Bear Case
$25.58
1,780.9%
Low target
Base Case
$37.94
+2,689.7%
Avg target
Bull Case
$45.71
+3,261.0%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$34.78
-96.1% from high
52-Week Low
$20.23
+-93.3% from low
Target vs 52W High
$37.94
+9.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%